ABSTRACT: Glioblastoma (GBM) resistance to therapy is the most common cause of tumor recurrence, which is ultimately fatal in 90 percent of the patients five years after initial diagnosis. A subpopulation of tumor cells with stem like properties are specifically endowed to resist or adapt to the standard therapies (e.g, radiation, chemotherapy) and lead to tumor resistance. ... Continue Reading